Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 28,750

Document Document Title
WO/2013/096998A1
The present invention refers to a process for production of a mix¬ ture comprising 2,4-furandicarboxyiic acid (2,4-FDCA) and 2,5 furandicar- boxyiic acid (2,5-FDCA) through the disproportionation route, using as base compounds oxidation...  
WO/2013/102015A1
Furfural is produced by contacting a feedstock solution containing C5 sugar and/or C6 sugar with a solid acid catalyst using reactive distillation. Both high yield and high conversion are obtained, without production of insoluble char in...  
WO/2013/097042A1
Disclosed is a compound of formula 1, as shown below, where R1, R2, R3, R4, R5, R6 and R7 are as described herein. Also, disclosed is a process for the preparation of compounds of formula 1, and intermediates used therein. The compound o...  
WO/2013/099553A1
Provided is a novel 2-fluorophenylpropionic acid derivative which has excellent anti-inflammatory/analgesic effects, while avoiding side effects such as gastrointestinal disorders, namely a 2-fluorophenylpropionic acid derivative represe...  
WO/2013/099998A1
The present invention is a radiation-sensitive resin composition which contains [A] a polymer that has a structural unit represented by formula (1) and [B] an acid generator. In formula (1), R2 represents a hydrogen atom or a monovalent ...  
WO/2013/102027A1
Furfural is produced by mixing an aqueous feedstock solution containing C5 sugar and/or C6 sugar with a heated high boiling, water-miscible solvent, such as sulfolane, and a solid acid catalyst. Furfural product and water can be distille...  
WO/2013/097752A1
Disclosed are natural products as retinoic acid receptor (RARs) excitomotors and the uses thereof. The marine natural products Luffariellolide and Manoalide are specific excitomotors of retinoic acid receptors (RARs), able to inhibit the...  
WO/2013/102000A1
Furfural is produced by contacting an aqueous feedstock solution containing C5 sugar and/or C6 sugar using a soluble acid catalyst with reactive distillation. Both high yield and high conversion are obtained in the reaction vessel. Degra...  
WO/2013/098416A2
The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.  
WO/2013/101999A1
Furfural is produced by mixing an aqueous feedstock solution containing C5 sugar and/or C6 sugar with a heated, high boiling, water-miscible solvent, such as sulfolane, and a soluble acid catalyst. Furfural product and water are distille...  
WO/2013/102002A1
Processes for making furfural and 5-hydroxymethylfurfural from sugars are provided. The processes can be carried out using a batch process or a continuous mode of operation. An aqueous sugar solution is pressurized with CO2, thereby prod...  
WO/2013/098416A3
The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.  
WO/2013/093322A1
The invention relates to a method for oxidizing 5-hydroxymethyl furaldehyde, including at least one step of oxidation in the presence of an organic acid, a nitroxyl radical, an oxygen source, and an oxygen transfer agent.  
WO/2013/091062A3
The present invention comprises aldimine-derived compounds, pharmaceutical compositions containing such compounds and pharmaceutically acceptable excipients, beside the use thereof for treating fungal infections of medicinal and/or veter...  
WO/2013/093508A3
A class of compounds having general formula (I) has been identified. These compounds function as inhibitors of the Wnt pathway. Compounds of formula (I) are suitable for the treatment and/or prevention of any condition or disease in whic...  
WO/2013/094676A1
A hydroxymethylfurfural derivative represented by general formula (A). In the formula, R is selected from the group consisting of formula (I), (II) HOOCCH2COCO-, (III) HOOCCH2CH2COCO-, and (IV) a hydrogen atom.  
WO/2013/093508A2
Wnt pathway inhibitors A class of compounds having general formula (I) has been identified. These compounds function as inhibitors of the Wnt pathway. Compounds of formula (I) are suitable for the treatment and/or prevention of any condi...  
WO/2013/094646A1
Provided are: a novel bis(hydroxyamide)-based acid dianhydride exhibiting high transparency and superior solubility in organic solvents; a method for producing same; and a polyimide obtained therefrom. The acid dianhydride compound is re...  
WO/2013/093528A1
The invention relates to a process for the preparation of travoprost of formula(I), comprising that, the compound of formula (II), is stereoselectively reduced, the resulting compound of formula (III), is if desired crystallized, the lac...  
WO/2013/087614A1
A process for preparing 5-hydroxymethylfurfural (HMF), characterized in that a) solutions (called starting solution hereinafter) comprising one or more saccharides and an organic solvent having a boiling point greater than 200°C (at sta...  
WO/2013/086634A1
Discloses is a process for preparation of a compound of formula 7, or a derivative thereof, wherein PG1 is an alcohol protecting group. Also, disclosed are intermediates and processes for their preparation. The compound of formula 7 can ...  
WO/2013/087523A1
A process for preparing solutions which comprise 5-hydroxymethylfurfural (HMF) and have reduced content of starting materials from the HMF synthesis or a reduced content of by-products of the HMF synthesis (called product solution herein...  
WO/2013/087765A1
The present invention relates to the manufacture of compounds of general formula I or III including nitrile functions. Specifically, the invention relates to the manufacture of compounds including nitrile functions from compounds which i...  
WO/2013/090041A1
A method to produce levulinic acid (LA) and gamma- valerolactone (GVL) from biomass-derived cellulose or lignocellulose by selective extraction of LA using GVL and optionally converting the LA so isolated into GVL, with no purifications ...  
WO/2013/087954A1
The present invention relates to the use of a compound of formula (I) for treating Alzheimer's disease, and in particular relates to a pharmaceutical composition that comprises said compound and to the use thereof for the treatment of Al...  
WO/2013/088972A1
Provided is a compound represented by general formula (1). (1) In general formula (1), R1 is either a protecting group for a hydroxyl group or a hydrogen atom. R2 is either a methyl group or an ethyl group.  
WO/2013/087613A1
A process for preparing 5-hydroxymethylfurfural (HMF), characterized in that a) solutions (called starting solution hereinafter) comprising a hexose and an organic solvent having a boiling point greater than 200°C (at standard pressure)...  
WO/2013/085243A1
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device containing the same. Using the organic electroluminescent compounds of the present invention, it is possible to manufac...  
WO/2013/083225A1
The invention relates to the use of specific glucuronolactone derivates as self-tanning substances, as tanning intensifiers for dihydroxyacetone or for a mixture of self-tanning substances containing dihydroxyacetone for modulation of th...  
WO/2013/083225A8
The invention relates to the use of specific glucuronolactone derivates as self-tanning substances, as tanning intensifiers for dihydroxyacetone or for a mixture of self-tanning substances containing dihydroxyacetone for modulation of th...  
WO/2013/083994A1
The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.  
WO/2013/085999A1
Described is a process to make hydroxymethylfurfural (HMF) from glucose. The process includes the steps of reacting a feedstock solution comprising glucose, in the presence of a homogeneous Bransted acid catalyst and a homogeneous Lewis ...  
WO/2013/085824A1
The present invention provides compounds having the general structural Formula (I): and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutica...  
WO/2013/079022A1
The present invention relates to the field of natural drugs and pharmaceutical chemistry, and more particularly to novel 2-aminated methylene or 2-esterified methylene tanshinone I derivatives of a general formula I or pharmaceutically a...  
WO/2013/079819A1
A method for preparing ketose sugars, characterised in that: 1/ at least one aldose sugar or a solution or a suspension of said sugar in water is solubilised, in at least one organic solvent; 2/ the organic solution obtained is brought i...  
WO/2013/079866A1
The invention relates to a method for preparing 5-amino-benzoyl-benzofuran derivatives having the general formula in which R1 is hydrogen or an alkyl or aryl group and R2 is hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group. Accordi...  
WO/2013/079017A1
The present invention relates to the field of natural drugs and pharmaceutical chemistry, and more particularly to novel 2-alkyl-or-aryl-substituted tanshinone I derivatives of a general formula I or pharmaceutically acceptable salts the...  
WO/2013/080742A1
Provided is a method for efficiently manufacturing monosaccharides, oligosaccharides, and furfurals from biomass. While continuously supplying an aqueous biomass suspension via a supply port of a continuous primary hydrolysis device and ...  
WO/2013/077385A1
An aromatic amine derivative represented by the general formula (1). In the general formula (1), R1-R5 and R7-R11 are each independently hydrogen atoms or substituents. In the general formula (1), R6 and R12 are represented by the genera...  
WO/2013/075399A1
Provided in the present invention are an unsaturated 5-membered benzo-heterocyclic compound with the structure as shown in general formula I or pharmaceutical salts thereof, and a preparation method, a pharmaceutical composition and the ...  
WO/2013/075596A1
The present invention relates to the synthesis and use of a pentabasic dihydrogen heterocyclic ketone derivative of general formula (I) used as a DHODH inhibitor for Plasmodium falciparum, and the compound related to the present inventio...  
WO/2013/075253A1
The present application provides compound of Formula (X) wherein A is an optionally substituted aliphatic or an optionally substituted aryl, and B is a moiety that stabilizes the partial positive charge at the carbon adjacent the divalen...  
WO/2013/076747A1
A process is described for the production of 1,4-butanediol and tetrahydrofuran by catalytic hydrogenation of dialkyl maleates. The process consists essentially in the following steps: a) hydrogenating a stream of dialkyl maleate in a fi...  
WO/2013/077405A1
Provided is an aromatic amine derivative represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general formu...  
WO/2013/077406A1
Provided is an aromatic amine derivatives represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general form...  
WO/2013/072830A9
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830A4
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830A1
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/069646A1
The purpose of the invention is to provide a polyimide offering excellent solubility in organic solvents, an acid dianhydride compound that is a monomer thereof, and a method for producing the same. An acid dianhydride represented by for...  
WO/2013/067578A1
Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated card...  

Matches 451 - 500 out of 28,750